Clinical application of biological markers for treatments of resectable non-small-cell lung cancers

We performed a clinical study to identify biological markers useful for the treatment of resectable non-small-cell lung cancers (NSCLCs). In all, 173 patients were studied. By immunohistochemistry, we evaluated the Ki-67 proliferation index, tumour vascularity, thymidylate synthase (TS), vascular en...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, C, Liu, D, Masuya, D, Nakashima, T, Kameyama, K, Ishikawa, S, Ueno, M, Haba, R, Yokomise, H
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361974/
https://www.ncbi.nlm.nih.gov/pubmed/15785747
http://dx.doi.org/10.1038/sj.bjc.6602481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361974/
https://www.ncbi.nlm.nih.gov/pubmed/15785747
http://dx.doi.org/10.1038/sj.bjc.6602481

Ejemplares similares